Evidence map›Paper›PMID 39331766›Full record

ArticleReproduction & fertility2024

Factors Influencing the Timing of Ovarian Tissue Cryopreservation in Young Girls.

Valentina Pampanini, Lena Sahlin, Elina Holopainen, Mervi Taskinen, Mikael Koskela, Kim Vettenranta, Jaana Vettenranta, Tiina Laine, Claudia Anderson, Kirsi Jahnukainen

Abstract read
In one paragraph

Article in Reproduction & fertility, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Valentina PampaniniV Pampanini, Bambino Gesu Pediatric Hospital, Roma, 00165, Italy.
Lena SahlinL Sahlin, Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
Elina HolopainenE Holopainen, Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.
Mervi TaskinenM Taskinen, Division of Hematology-Oncology and Stem Cell Transplantation, Helsinki University Central Hospital, Helsinki, Finland.
Mikael KoskelaM Koskela, Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.
Kim VettenrantaK Vettenranta , Division of Hematology-Oncology and Stem Cell Transplantation, Helsinki University Central Hospital, Helsinki, Finland.
Jaana VettenrantaJ Vettenranta, Division of Hematology-Oncology and Stem Cell Transplantation, Helsinki University Central Hospital, Helsinki, Finland.
Tiina LaineT Laine, Pediatric Research Center, Helsinki University Central Hospital, Helsinki, Finland.
Claudia AndersonC Anderson, Pediatric Research Center, Helsinki University Central Hospital, Helsinki, Finland.
Kirsi JahnukainenK Jahnukainen, Division of Hematology-Oncology and Stem Cell Transplantation, Helsinki University Central Hospital, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to identify pitfalls in ovarian tissue cryopreservation protocol from referral to surgical procedure and to analyze factors associated with chemotherapy exposure of the cryopreserved tissue and decreased ovarian function in a cohort of young girls at high risk of infertility. The study population comprised 200 girls eligible for ovarian tissue cryopreservation between 2002 and 2020 at the Children's Hospital of the University Central Hospital of Helsinki (Finland). Analyses included evaluation of the proportion of patients who underwent ovarian tissue cryopreservation, factors associated with patient selection and timing of ovarian tissue cryopreservation, and ovarian function during long-term follow-up in relation to oncological treatments. Lack of counselling was identified as the major reason for not receiving ovarian tissue cryopreservation. A longer interval from scheduling gonadotoxic therapy to cryopreservation correlated with a higher exposure to alkylating agents of the ovarian tissue. The long-term ovarian function was mainly influenced by age at the time of gonadotoxic treatment. Current selection criteria for ovarian tissue cryopreservation should be implemented in order to stratify patients at risk of infertility and timely identify those at higher risk, especially in relation to age and pubertal stage. Efforts to increase healthcare providers' awareness and facilitate guided timing in relation to the treatment protocols are needed to guarantee early access to ovarian tissue cryopreservation for all patients at high risk of infertility.

Identifiers

PMID39331766
PMCPMC11558924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.